203 related articles for article (PubMed ID: 18195728)
1. A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
Cross JT; Poole EM; Ulrich CM
Pharmacogenomics J; 2008 Aug; 8(4):237-47. PubMed ID: 18195728
[TBL] [Abstract][Full Text] [Related]
2. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
Samowitz WS; Wolff RK; Curtin K; Sweeney C; Ma KN; Andersen K; Levin TR; Slattery ML
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):894-901. PubMed ID: 16797247
[TBL] [Abstract][Full Text] [Related]
3. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy.
Spangler RS
Semin Arthritis Rheum; 1996 Aug; 26(1):435-46. PubMed ID: 8870111
[TBL] [Abstract][Full Text] [Related]
5. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.
St Germaine CG; Bogaty P; Boyer L; Hanley J; Engert JC; Brophy JM
Am J Cardiol; 2010 Jun; 105(12):1740-5. PubMed ID: 20538124
[TBL] [Abstract][Full Text] [Related]
8. Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer.
Andersen V; Vogel U
Aliment Pharmacol Ther; 2014 Jul; 40(2):147-59. PubMed ID: 24889212
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Pharmacogenet Genomics; 2009 Feb; 19(2):113-20. PubMed ID: 19077918
[TBL] [Abstract][Full Text] [Related]
12. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages.
Barnard ME; Hecht JL; Rice MS; Gupta M; Harris HR; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1509-1517. PubMed ID: 30377203
[TBL] [Abstract][Full Text] [Related]
14. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
15. Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer.
Hahn E; Kraus S; Arber N
Dig Dis; 2010; 28(4-5):585-9. PubMed ID: 21088406
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer.
Levy GN
FASEB J; 1997 Mar; 11(4):234-47. PubMed ID: 9068612
[TBL] [Abstract][Full Text] [Related]
18. Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.
Chia VM; Newcomb PA; Bigler J; Morimoto LM; Thibodeau SN; Potter JD
Cancer Res; 2006 Jul; 66(13):6877-83. PubMed ID: 16818666
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
[TBL] [Abstract][Full Text] [Related]
20. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain.
Fortuny J; Kogevinas M; Garcia-Closas M; Real FX; Tardón A; Garcia-Closas R; Serra C; Carrato A; Lloreta J; Rothman N; Villanueva C; Dosemeci M; Malats N; Silverman D
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1696-702. PubMed ID: 16985032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
